# Carbon Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/carbon-biosciences

- Industry: Biotechnology
- Headquarters: Lexington, US
- Website: www.carbonbio.com
- Total disclosed funding: $38M
- Latest round: Series A (Jan 10, 2022)
- Investors on record: 7

## About

Founded in 2021 and based in Massachusetts, US, Carbon Biosciences operates as a developer of gene therapy for the treatment of difficult-to-treat diseases.

## Funding rounds

- Series A, Jan 10, 2022, $38M — Astellas Venture Management, Longwood Fund, Cystic Fibrosis Foundation, UTokyo Innovation Platform, Agent Capital, Solasta Ventures, Camford

## Investors

- Astellas Venture Management (https://capitalatlas.ai/funds/astellas-venture-management) — Series A
- Longwood Fund (https://capitalatlas.ai/funds/longwood-fund) — Series A
- Cystic Fibrosis Foundation — Series A
- UTokyo Innovation Platform (https://capitalatlas.ai/funds/utokyo-innovation-platform) — Series A
- Agent Capital (https://capitalatlas.ai/funds/agent-capital) — Series A
- Solasta Ventures (https://capitalatlas.ai/funds/solasta-ventures) — Series A
- Camford (https://capitalatlas.ai/funds/camford) — Series A